40 results about "Therapy control" patented technology

According to an aspect, an improved modular wearable medical device for monitoring a patient's ECG signals and providing therapeutic shocks in the event of a cardiac arrhythmia is provided. The device includes a garment, a plurality of ECG sensing electrodes that are permanently coupled at first predetermined locations on the garment, at least one pocket or receptacle disposed on the garment and configured to removably secure a module with device electronics within a housing to the garment, a plurality of wires or cables permanently integrated into the garment and operably coupling the plurality of permanently coupled ECG sensing electrodes with the sensor interface module, a plurality of therapy electrodes removably coupled to second predetermined locations on the garment, gel deployment circuitry, one or more capacitors, and a therapy control module configured to control the provision of the therapeutic shocks.

Disclosed is a minimally-invasive sensing device for measuring or estimating respiratory biomarkers. The device contacts a target body fluid detects for at least one target analyte and outputs a signal representative of a concentration of the analyte, from which biomarker information is determined. The present disclosure also relates to methods and systems using measurements or estimations of respiratory biomarkers to assess patient respiratory state, and / or assist in providing respiratory therapy to a patient.

The present disclosure relates to devices, systems, and methods for high frequency chest wall concussion (HFCWO) therapy that can promote mucous drainage by preferential impacts on a user, including by continuously applying pressure to the chest engaging device to provide HFCWO, to enhance sputum excretion. A chest wall concussion therapy system of the present disclosure may include a chest engagement device for transmitting an impact force to a patient's chest and a force generator arranged to generate a continuous impact force as a patient treatment regimen. The thoracic wall concussion therapy system additionally comprises a therapy control system comprising at least one sensor arranged to detect an indication of a breathing pattern of the patient.

The utility model provides a BNCT treatment room safety interlocking system, and relates to the technical field of BNCT treatment. The safety interlocking system can effectively overcome the false alarm defect of a safety interlocking system in the prior art, and specifically comprises treatment room equipment and a safety interlocking module, the treatment room equipment comprises a dose control module used for obtaining neutron beam flux and monitoring the neutron beam state, and a treatment control box used for controlling operation of the treatment terminal. The safety interlocking module is in communication connection with the dose control module through a first heartbeat detection line and a first alarm line which are independently arranged, and is in communication connection with the treatment control box through a second heartbeat detection line and a second alarm line which are independently arranged.

The present disclosure provides a device and a method for neuromodulation treatment. The neuromodulation device comprises a pulse generator to generate electrical pulses and at least one active electrode coupled to the pulse generator. The at least one active electrode has an electrically conductive surface configured to be attached to a leg of a patient. The at least one active electrode stimulates via the electrically conductive surface a nerve of the leg of the patient by the electrical pulses generated by the pulse generator. A control unit controls the pulse generator and sets at least one parameter of the generated electrical pulses. A response detector detects a response of the patient to the nerve stimulation and provides feedback on the detected response to the control unit. For the treatment the control unit determines a treatment setting by varying an initial setting of the at least one parameter of the generated electrical pulses until the detected response of the patient to the nerve stimulation is within a predetermined range.

A system (100) for respiratory therapy may include a pressure generator for a patient respiratory interface that delivers therapy to the user's airway, a user interface, and a controller coupled to the pressure generator configured to operate the generator for the therapy. The controller may be configured to, in a therapy mode, control the generator to deliver the therapy for a therapy session. The controller may be configured to, in a set-up configuration mode, receive an input by the user made on the user interface which corresponds to an adjustment to the parameter(s). The controller, in the set-up mode, may control generation of a user perceivable sensory response in real time or near real time in response to the adjustment to the parameter(s), including controlling the generator to deliver the therapy comprising the pressurized flow of breathable gas to the user's airway based on the received input and corresponding adjustment.

The application provides a beam control system for BNCT treatment, which comprises a treatment control module, an accelerator control module and a flux monitoring module; the treatment control module is used for acquiring a delivery dose and a delivery time of the BNCT in real time, triggering a stop beam instruction based on the delivery dose or the delivery time, and transmitting the stop beam instruction to the accelerator control module to terminate the delivery of the neutron beam; the accelerator control module is used for receiving the stop beam instruction to correspondingly turn off the proton beam to terminate the delivery of the neutron beam, and automatically turn off the proton beam when an abnormal situation occurs; and the flux monitoring module is used for monitoring the neutron flux in real time and transmitting monitoring data to the treatment control module to enable the treatment control module to acquire the delivery dose based on the monitoring data in real time. The application realizes accurate control of the delivery of the beam and real-time monitoring of the delivery dose and the delivery time in the process of the BNCT treatment, and ensures the accuracy and safety of the delivery of the beam of the equipment.

The invention relates to the technical field of intelligent medical control and low-temperature plasma medical application, in particular to an intelligent decision-making system for CAP treatment of nephropathy skin complications based on multi-parameter dynamic monitoring. Comprising a multi-modal physical sign acquisition module which is used for acquiring multi-dimensional physiological characterization signals of local tissues and synchronously acquiring periodic metabolism interference data containing dialysis time sequence information; the tolerance threshold inversion module is used for obtaining a local tissue oxidation-reduction tolerance threshold through inversion by using a tissue oxidation-reduction tolerance calculation model; the dynamic interference compensation module is used for generating a real-time safety boundary threshold value; the adaptive strategy generation module is used for generating candidate treatment control strategies by using a deep reinforcement learning algorithm; the risk boundary control module is used for calculating an expected oxidative stress level, if the expected oxidative stress level is larger than or equal to a real-time safety boundary threshold value, blocking or degrading operation is executed, and otherwise, a final treatment instruction is output; the therapeutic dose control precision is improved to the physiological response level, and the iatrogenic skin necrosis risk is effectively avoided.

The invention relates to a non-invasive method for detecting respiratory gases comprising hydrogen sulfide, in particular for use in the medicine, diagnosis, prediction, risk stratification, and therapy control for diseases, in particular intestinal diseases, of test subjects, wherein gases formed by bacteria are detected in the exhaled gas, and the hydrogen sulfide is not disadvantageously degraded.

A medical device is configured to sense at least one cardiac electrical signal and generate pacing pulses according to a first pacing therapy by generating pacing pulses for delivery to a first combination of ventricular pacing sites including at least one ventricular conduction system pacing site. The medical device may be configured to determine a ventricular conduction condition based on a QRS signal feature of the sensed cardiac signal during the first pacing therapy. The medical device may change to a second pacing therapy different than the first pacing therapy based on the determined ventricular conduction condition.

The invention provides a debugging method and device of a treatment control system, electronic equipment, a medium and a program product, and can be applied to the technical field of computers. The debugging method of the treatment control system comprises the following steps: in response to a received motion control instruction of the treatment control system, controlling a virtual multi-degree-of-freedom mechanical arm to move, and performing collision detection in the movement process to generate collision detection data; debugging the treatment control system according to the collision detection data; in response to a received image acquisition instruction of the treatment control system, controlling the virtual image equipment to perform image acquisition on a virtual target region of the digital twin platform, generating a virtual medical image and sending the virtual medical image to the treatment control system; in response to a received position correction instruction fed back by the treatment control system based on the virtual medical image, correcting the pose of the virtual target region according to the position correction instruction, and generating pose feedback data according to a correction result; and debugging the treatment control system according to the pose feedback data.

The application discloses a short-wave ultraviolet irradiation-based stomach disease treatment instrument, and belongs to the technical field of medical equipment.The application comprises a treatment instrument main body, a main pipe body, a probe end, an ultraviolet emission end and a treatment control module for controlling the treatment instrument main body; the modular design of the treatment instrument main body and the combination with the ultraviolet emission end improve the clinical operability and treatment effect, the combination with the rotary toothed disc driving mechanism enables the ultraviolet emission end to realize all-around twisting, covers the stomach area, the light-transmitting layer blocks infrared radiation while ensuring the ultraviolet transmittance, reduces the thermal stimulation on the stomach tissue, and enables medical staff to observe the irradiation effect in real time, realizes visual treatment, the treatment control module realizes the precision and intelligence of stomach disease treatment through a multi-unit cooperative architecture, generates a personalized scheme based on the disease type and the lesion position, monitors the physiological indexes of patients in real time and dynamically adjusts the treatment parameters, and improves the treatment safety and effectiveness.

The disclosure a method for centralized control and display in a urological operating room. The method comprises receiving, at a single control device, physiological information from a plurality of therapy consoles provisioned in an operating theater; generating, at the single control device, a composite display comprising combined visual indications from multiple ones of the plurality of therapy consoles; receiving, at the single control device, control inputs from a user; generating control signals based on the control inputs; and sending the control signals from the single control device to at least one of the multiple ones of the plurality of therapy consoles to provide real-time control of an operational parameter of the at least one of the multiple therapy consoles, wherein the single control device is configured to provide both centralized display of information from all therapy consoles and centralized control of all therapy consoles through the composite display.

An ultrasound therapy system has both a therapy transducer configured to transmit therapeutic ultrasound energy toward a target tissue and an imaging transducer configured to image the target tissue over a three-dimensional volume. The transducers are preferably arranged in a common housing but have respective controllers. The therapy controller causes the therapy transducer to focus the therapeutic ultrasound energy at a selectable focal position within a three-dimensional treatment region and the imaging controller generates a three-dimensional image of the target tissue, which is displayed for viewing by a user. Target location information is then transferred from the imaging controller to the therapy controller. The therapy controller adjusts the focal position of the therapeutic ultrasound energy within the three-dimensional treatment region accordingly.

Disclosed is a wearable cardiac therapeutic system including a plurality of therapy electrodes disposed in a garment and a fluid pressure source including a barrel configured to house conductive gel, and an actuation mechanism. A therapy controller is configured to detect an arrhythmic event in a patient based on sensed electrical activity of the patient's heart, initiate an activation signal indicating that the conductive gel is to be released on to the body of the patient, and cause the delivery of one or more electrical therapeutic shocks to the heart of the patient. Gel activator circuitry is configured to receive the activation signal from the therapy controller, and cause the fluid pressure source to expel the conductive gel onto the body of the patient proximate the one or more of the therapy electrodes and prior to the delivery of the one or more electrical shocks to the patient.

The present application relates to the technical field of radiotherapy control, and discloses a treatment control method and system for AB-BNCT. The method comprises the following steps: sending a beam-out condition verification request and a beam-out safety verification request in response to a beam-out request; sending a beam-out button display instruction after receiving the pass results, so that the beam-out button is displayed based on a preset state; monitoring main real-time beam data in real time in response to a state change of the beam-out button; determining a main real-time neutron absorption dose based on the main real-time beam data; and sending a beam control instruction to an accelerator based on the main real-time neutron absorption dose and a target neutron absorption dose, so that the accelerator controls the beam in response to the beam control instruction. By comparing the real-time dose with the target dose, the treatment is continued or stopped, and the accuracy of the treatment and the safety of the patient are ensured. The present application solves the technical problems of low safety and dose verification lag in the existing AB-BNCT treatment, and improves the safety and efficiency of AB-BNCT treatment.

The present application relates to the technical field of intelligent monitoring, in particular to a child rhinitis nebulization treatment control system and method based on behavior guidance and intelligent monitoring, the system comprising: a voice emotion analysis module, a respiratory airflow monitoring module, a rhythm feature quantification module, a respiratory behavior guidance module, and a nebulization drug release control module.In the present application, the internal emotional tendency is quantified by extracting the audio spectrum features to establish the classification boundary and determine the mapping relationship between the acoustic parameters and the state code, then the multi-dimensional respiratory airflow extreme value data is collected and the adjacent time stamp difference points are matched to calculate the duration of a specific stage, the deep breathing features are constructed, the rhythm deviation degree is fused with the reference amplitude to generate a compensation factor to update the visual animation track to realize dynamic intervention guidance, the guided parameters and the state code are spliced and fused, the rate adjustment instruction is generated according to the comprehensive judgment result, and the on-demand drug delivery for different deep and shallow breathing rhythms is realized to avoid drug liquid waste and greatly improve the absorption and conversion effect.

Disclosed is an exercise therapy control apparatus using a UI that includes a segment selection progress bar, comprising: a signal input device for receiving a point selection signal from a patient in a step of generating therapy for the patient by a robot; a display for displaying a therapy setting UI for selecting at least one segment in a therapy progress step; and a processor for performing a segment setting process in the therapy progress step by means of the therapy setting UI.

The present disclosure provides radiotherapy control and radiotherapy plan generation methods, device, and system, and a medium. The method includes: controlling a diagnosis-treatment integrated couch to move a target object to a diagnostic device, so as to acquire a diagnostic image of the target object through the diagnostic device; and controlling the diagnosis-treatment integrated couch to move the target object from the diagnostic device to a radiotherapy device, and synchronously triggering generation of a radiotherapy plan for the target object based on the diagnostic image.

The present invention relates to a multifunctional therapeutic system comprising a handheld controller, a therapeutic device, and a base for secure placement and operation. The handheld controller includes a housing accommodating a rechargeable battery, control board, button module, display screen, and a phototherapy assembly with lamp beads and concentrator lenses, enabling localized body treatment. The therapeutic device may be a light therapy mask, cap, pad, or other treatment module, comprising inner and outer shells, light panels, and positioning structures to ensure comfort, precise fit, and uniform illumination. The base includes slots and receiving cavities configured to hold the controller and therapeutic device, allowing secure mounting, easy insertion, and removal. The system supports independent or simultaneous operation of the controller and therapeutic device, enhancing versatility, usability, and user comfort while delivering effective phototherapy across multiple body regions.

The application discloses a kind of epilepsy closed loop intelligent processing method based on micro machine learning.The method comprises: the pre-processing of input electroencephalogram signal;Lightweight one-dimensional convolutional neural network model is used to analyze and judge the electroencephalogram feature after processing, and when the seizure state is identified, the treatment control module is triggered to output pulse signal, guides nerve stimulation device to intervene epilepsy, and realizes closed loop treatment.The present application is based on embedded platform, with the advantages of fast response, efficient calculation, wearable, etc., suitable for real-time epilepsy monitoring and intervention in family and mobile scene, effectively improve the intelligent and personalized level of epilepsy management.

The invention relates to the technical field of radiotherapy control, and discloses a treatment control method and system for AB-BNCT. The method comprises the following steps: sending a beam outgoing condition verification request and a beam outgoing security verification request in response to a beam outgoing request; after the passing results are received, a beam-out button display instruction is sent, so that a beam-out button is displayed based on a preset state; monitoring main real-time beam data in real time in response to the state change of the beam output button; determining a main real-time neutron absorption dose based on the main real-time beam data; and sending a beam control instruction to the accelerator based on the main real-time neutron absorption dose and the target neutron absorption dose, so that the accelerator controls the beam in response to the beam control instruction. By comparing the real-time dose with the target dose, the treatment is continued or stopped, so that the treatment accuracy and the patient safety are ensured. According to the invention, the technical problems of low safety, dose verification lag and the like in the existing AB-BNCT treatment are solved, and the safety and efficiency of the AB-BNCT treatment are improved.

1. The name of the design product: moxibustion therapy control graphical user interface for electronic equipment. 2. The use of the design product: for an electronic device. 3. The design points of the design product: in the graphical user interface. 4. The picture or photo that best indicates the design points: front view. 5. The electronic device is a conventional design, and other views are omitted. 6. The use of the graphical user interface: for controlling the collaborative robot to perform moxibustion therapy operation tasks; the front view clicks any order to display change state diagram 1, change state diagram 1 adjusts the value and clicks "confirm" to display change state diagram 2, change state diagram 2 clicks "start therapy" to display change state diagram 3, change state diagram 3 selects the ignition mode to display change state diagram 4, and change state diagram 4 clicks "end" to display change state diagram 5.

The proposed group of inventions relates to the medical field, in particular to methods for the treatment, management, and prevention of pain using the tetrapeptide tyrosyl-D-arginyl-phenylalanyl-glycinamide (H-Tyr-D-Arg-Phe-Gly-NH2), and to pharmaceuticals based on this tetrapeptide. These can be used to treat acute or chronic pain, particularly in cancer patients and in the early postoperative period after various surgical procedures. A method for the treatment, management, and prevention of pain is proposed, which involves administering H-Tyr-D-Arg-Phe-Gly-NH2 in a single dose of 2 to 7 mg, not exceeding 42 mg per day, with at least 4 hours between doses, for a maximum pain treatment course of 96 days, with the possibility of repeating the course multiple times.

The present application relates to the technical field of medical instrument control, in particular to a depth controllable piezoelectric shock wave treatment system based on automatic focusing. A data acquisition module system collects sample data of patients with the same disease type, including historical and to-be-tested samples, covering multi-dimensional information such as treatment feedback text and treatment area characteristic parameters. Due to individual differences among patients, a sample data analysis module obtains sample tolerance sensitivity by analyzing pain test data, determines the influence degree of complications by comparing treatment feedback texts, and accurately grasps the physiological and pathological characteristics of individual patients. A linkage characteristic analysis module comprehensively considers similar characteristics such as treatment area characteristic parameters, determines the linkage characteristic performance degree among samples, and excavates the internal relationship and similar rules. A treatment control parameter determination module trains a neural network based on the linkage characteristic performance degree and treatment control parameters, accurately determines the treatment control parameters of the to-be-tested sample by using the learning and prediction ability of the neural network, and avoids over-treatment or under-treatment.

The present disclosure relates to devices, systems, and methods for high frequency chest wall oscillation (HFCWO) therapy that can enhance mucus clearance by preferentially impacting a user, including by continuously applying pressure to a chest engagement device to provide HFCWO. Chest wall oscillation therapy systems of the present disclosure can include a chest engagement device for transmitting an impact force to a patient's chest and a force generator arranged to generate a continuous impact force as a patient therapy regimen. The chest wall oscillation therapy system additionally includes a therapy control system including at least one sensor arranged to detect an indication of a patient's breathing pattern.

The embodiment of the invention discloses a treatment control method, a treatment handle and a storage medium, and is applied to the technical field of medical treatment. The treatment control method is applied to a treatment handle, an ultrasonic transducer is installed on the treatment handle, the ultrasonic transducer emits focused ultrasonic waves, and after the treatment face of the treatment handle is attached to the skin, the ultrasonic transducer is controlled to move on the treatment handle in a reciprocating mode. In the reciprocating displacement process of the ultrasonic transducer, the displacement information of the ultrasonic transducer is detected, and the ultrasonic transducer is controlled to emit focused ultrasonic waves to the skin according to the corresponding energy sequence based on the displacement information, so that the focused ultrasonic waves emitted by the ultrasonic transducer can be matched with the displacement process of the ultrasonic transducer; the ultrasonic transducer emitting focused ultrasonic waves can accurately output energy.

The disclosure provides a centralized urology operating room control system. The centralized urology operating room control system comprising: therapy consoles selected from a group consisting of a prostate treatment console, a stone treatment console, a tabletop laser therapy console, and an endoscope control console; and a centralized urology control assembly comprising: a housing configured to house at least: a communications console comprising a speaker; a centralized controller, wherein the centralized controller includes a memory storing non-transitory instructions and a hardware processor that is configured to execute the instructions to cause display of a single user interface, via a display, at least for monitoring operation of the therapy consoles; and a power input console configured to provide single-source power to at least the communications console and the centralized controller.

A pulse field ablation system may include a first elongate shaft, a second elongate shaft, one or more electrodes, a wave generator, and a treatment control module. The first elongate shaft may include one or more lumens with a first lumen configured to pass a fluid to treat a thrombus in a vessel of a subject. The second elongate shaft may be configured to extend in a distal direction beyond a distal end of the first shaft. The one or more electrodes may be disposed at a distal portion of the second elongate shaft. The wave generator may be configured to be in electrical communication with the one or more electrodes. The treatment control module may selectively cause the wave generator to deliver energy to an electrode of the one or more electrodes, where the energy may be configured to lyse red blood cells of the thrombus.